KALA BIO, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-108.2M | $-108.2M | — | $16.1M |
| FY2022 | $-78.9M | $-78.9M | — | $7.0M |
| FY2023 | $-27.9M | $-27.9M | — | $7.5M |
| FY2024 | $-29.4M | $-29.4M | — | $8.4M |
| FY2025 | $-32.0M | $-32.0M | — | $7.0M |